3Kurz PA,Moorthy RS,Fountain JA,et al.Treatment of refractory macular edema with intraocular triamcinolone acetonide.Graefes Arch Clin Exp Ophthal,2002,240:42-48.
4Jonas JB,Cofker A.Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.Am J Ophthalmol,2001,131:468-471.
5Aysel Kukner,Neriman Colakoglu,Didem Serin,et al.Effects of intraperitoneal vitamin E:melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis.Acta Ophthalmol Scand,2006,84:54-61.
7Gregori NZ,Rosenfeld P J,Puliafito CA,et al.One year safety and efficacy of intravitreal Triamcinolone Acetonide for the management of macular edema secondary to central retinal vein occlusion.Retina,2006,26:889-895.
6LashayAR, Rahimi A,Chams H,et al. Evaluation of the effect of acetzolamide on cystoid macular edema in patients with Behcet′s disease. Eye,2003,17:762-766.
7Kobayashi H,Kobayashi K,Okinami S. Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. Am J Ophthalmol, 2003,136:244-251.
8Campochiaro PA,The C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci, 2004,45: 922-931.
9Danis RP,Bingaman DP,Yang Y,et al. Inhibition of preretinal and optic nerve head neovascularization in pig by intravitreal triamcinolone acetonide. Ophthalmol,1996,103: 2099-2104.
2Wensing B, Relvas LM, Caspers LE, et al. Comparison of rubella vi rus-and herpes virus-associated anterior uveitis: clinical manifestation and visual prognosis[J]. Ophthalmology, 2011,118(10) : 1905-1910.
3Mnckensen F, David F, Schwenger V, et al. HLA-DRB1 * 0102 is associated with TINU syndrome and bilateral, sudden-onset anterior u- veitis but not with interstitial nephritis alone [ J ]. British Journal of Ophthalmology, 2011, 95 (7) : 971-975.
4Li W, Backhouse O, Xie T, et al. A double-blind placebo phase 3 randomised controlled trial of Chinese herbal medicine in anterior uvei- tis[J]. European Journal of Integrative Medicine, 2013, 5(6) : 577.
5Chang J H, McCluskey P J, Wakefield D. Recent advances in Toll - like receptors and anterior uveitis [ J ]. Clinical & Experimental Oph- thalmology, 2012, 40(8): 821-828.
6YChang 3 I-I, McCluskey P J, Wakefield D. Recent advances in Toll- like receptors and anterior uveitis[ J]. Clinical & Experimental Oph- thalmology, 2012, 40(8) : 821-828.
7Cohen A E, Assang C, Patane M A, et al. Evaluation of dexametha- sone phosphate delivered by ocular iontophoresis for treating noninfec- tious anterior uveitis[J]. Ophthalmology, 2012, 119( 1 ) : 66-73.
8Wakefield D, Gray P, Chang J, et al. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis [ J ]. British Journal of Ophthalmology, 2010, 94(3 ): 271-274.
9Yang M, Lai T Y Y, Tam P O S, et al. Association of C2 and CFB polymorphisms with anterior uveitis [ J ]. Investigative Ophthalmology & Visual Science, 2012, 53 (8) : 4969-4974.
10Molina C, Modesto C, Martin-Begu6 N, et al. Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with ju- venile idiopathic arthritis[J]. Clin Rheum, 2013, 32(11 ): 1673-1675.
